This legislation establishes a clear federal framework for the hemp industry by setting consistent standards for cultivation, manufacturing, testing, and labeling, while prohibiting synthetic cannabinoids in finished hemp-derived products.
Will prohibit synthetic cannabinoids and other non-naturally occurring compounds in finished hemp-derived products.
Occurrences
Evidence
legacy_unverified · Source version not recorded · locator unknown
Section 781 states that, effective 365 days after enactment, 7 U.S.C. 1639o is amended so hemp excludes final hemp-derived cannabinoid products containing cannabinoids not naturally produced by Cannabis sativa L. or cannabinoids naturally producible but synthesized or manufactured outside the plant.
legacy_unverified · Source version not recorded · locator unknown
The Clerk records Roll Call 285 on H.R. 5371, motion to concur in the Senate amendment, as passed 222-209; Representative Barr, Republican of Kentucky, voted Yea.
Assessments
The promised federal prohibition was enacted in Public Law 119-37 during Barr's current House term. Section 781 amends the hemp definition to exclude final hemp-derived cannabinoid products containing cannabinoids not naturally produced by Cannabis sativa L. or synthesized/manufactured outside the plant, matching the claim. Although the operative date is November 12, 2026, enactment of the binding statutory prohibition is sufficient for delivery. Barr also voted for final passage, giving direct same-term candidate credit.